James H. Mackaness, CFO of Soleno Therapeutics Inc. ($SLNO), sold shares on the open market 11 times over the past year, totaling $6.3 million. His most recent sale occurred on March 27, 2025. These sales rank 1,634th among 11,678 individual insiders in our database, where the average is $8.6 million across about six transactions. He made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 21, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | A | Common Stock | 28600 | $0.00 | 131,763.0000 | 54,921,916 | 27.72% | 0.05% |
| Jan. 21, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | A | Employee stock option (right to buy) | 32800 | $0.00 | 32,800.0000 | 54,921,916 | 9999.99% | 0.06% |
| Dec. 15, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | F | Common Stock | 2013 | $49.95 | 103,163.0000 | 54,921,916 | 1.91% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 563 | $71.74 | 105,262.0000 | 40,175,926 | 0.53% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 86 | $72.64 | 105,176.0000 | 40,175,926 | 0.08% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | M | Common Stock | 20000 | $30.75 | 125,176.0000 | 40,175,926 | 19.02% | 0.05% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | M | Common Stock | 10000 | $5.10 | 135,176.0000 | 40,175,926 | 7.99% | 0.02% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | M | Common Stock | 5000 | $2.60 | 140,176.0000 | 40,175,926 | 3.70% | 0.01% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | M | Common Stock | 15000 | $2.41 | 155,176.0000 | 40,175,926 | 10.70% | 0.04% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | M | Common Stock | 20000 | $5.25 | 175,176.0000 | 40,175,926 | 12.89% | 0.05% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 25799 | $69.07 | 149,377.0000 | 40,175,926 | 14.73% | 0.06% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 36157 | $70.03 | 113,220.0000 | 40,175,926 | 24.21% | 0.09% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 8044 | $70.80 | 105,176.0000 | 40,175,926 | 7.10% | 0.02% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | M | Employee stock option (right to buy) | 20000 | $0.00 | 0.0000 | 40,175,926 | 100.00% | 0.05% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | M | Employee stock option (right to buy) | 10000 | $0.00 | 3,000.0000 | 40,175,926 | 76.92% | 0.02% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | M | Employee stock option (right to buy) | 5000 | $0.00 | 0.0000 | 40,175,926 | 100.00% | 0.01% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | M | Employee stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 40,175,926 | 50.00% | 0.04% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | M | Employee stock option (right to buy) | 20000 | $0.00 | 67,251.0000 | 40,175,926 | 22.92% | 0.05% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 1669 | $65.97 | 124,129.0000 | 40,175,926 | 1.33% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 3762 | $69.84 | 106,212.0000 | 40,175,926 | 3.42% | 0.01% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 387 | $70.73 | 105,825.0000 | 40,175,926 | 0.36% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 2717 | $66.79 | 121,412.0000 | 40,175,926 | 2.19% | 0.01% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 4940 | $67.70 | 116,472.0000 | 40,175,926 | 4.07% | 0.01% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 6498 | $68.79 | 109,974.0000 | 40,175,926 | 5.58% | 0.02% |
| Jan. 21, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | A | Employee stock option (right to buy) | 31000 | $0.00 | 31,000.0000 | 40,175,926 | 9999.99% | 0.08% |
| Jan. 21, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | A | Common Stock | 14500 | $0.00 | 125,798.0000 | 40,175,926 | 13.03% | 0.04% |
| Jan. 2, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 321 | $45.92 | 115,089.0000 | 40,175,926 | 0.28% | 0.00% |
| Jan. 3, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 3791 | $46.18 | 111,298.0000 | 40,175,926 | 3.29% | 0.01% |
| Jan. 2, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 3762 | $45.37 | 115,410.0000 | 40,175,926 | 3.16% | 0.01% |
| Oct. 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 829 | $50.25 | 119,172.0000 | 41,879,025 | 0.69% | 0.00% |
| Oct. 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 7248 | $49.34 | 120,001.0000 | 41,879,025 | 5.70% | 0.02% |
| Aug. 28, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 3100 | $48.03 | 134,119.0000 | 16,492,132 | 2.26% | 0.02% |
| Aug. 29, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 5595 | $47.16 | 128,524.0000 | 16,492,132 | 4.17% | 0.03% |
| Aug. 29, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 1275 | $47.83 | 127,249.0000 | 16,492,132 | 0.99% | 0.01% |
| Aug. 28, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 3561 | $47.19 | 137,219.0000 | 16,492,132 | 2.53% | 0.02% |
| Aug. 6, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 799 | $43.64 | 148,115.0000 | 16,492,132 | 0.54% | 0.00% |
| Aug. 5, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 3858 | $45.48 | 151,905.0000 | 16,492,132 | 2.48% | 0.02% |
| Aug. 5, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 2991 | $46.14 | 148,914.0000 | 16,492,132 | 1.97% | 0.02% |
| Aug. 6, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 2699 | $45.25 | 145,416.0000 | 16,492,132 | 1.82% | 0.02% |
| Aug. 6, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 4636 | $45.89 | 140,780.0000 | 16,492,132 | 3.19% | 0.03% |
| July 17, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | A | Common Stock | 100000 | $0.00 | 155,763.0000 | 16,492,132 | 179.33% | 0.61% |
| July 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 1568 | $41.22 | 61,385.0000 | 16,492,132 | 2.49% | 0.01% |
| July 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 5622 | $41.63 | 55,763.0000 | 16,492,132 | 9.16% | 0.03% |
| April 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 3104 | $41.12 | 65,024.0000 | 16,492,132 | 4.56% | 0.02% |
| April 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | CHIEF FINANCIAL OFFICER | S | Common Stock | 2071 | $41.67 | 62,953.0000 | 16,492,132 | 3.18% | 0.01% |
| Jan. 4, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | A | Common Stock | 56000 | $0.00 | 68,128.0000 | 16,492,132 | 461.74% | 0.34% |
| Jan. 4, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | A | Employee stock option (right to buy) | 37000 | $0.00 | 37,000.0000 | 16,492,132 | 9999.99% | 0.22% |
| Dec. 11, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | S | Common Stock | 13849 | $37.06 | 12,128.0000 | 8,397,088 | 53.31% | 0.16% |
| Dec. 11, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | M | Employee stock option (right to buy) | 15000 | $0.00 | 5,000.0000 | 8,397,088 | 75.00% | 0.18% |
| Oct. 2, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | M | Common Stock | 2666 | $4.50 | 36,236.0000 | 8,397,088 | 7.94% | 0.03% |
| Oct. 2, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | M | Common Stock | 2143 | $1.75 | 38,379.0000 | 8,397,088 | 5.91% | 0.03% |
| Oct. 2, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | M | Common Stock | 3500 | $2.50 | 41,879.0000 | 8,397,088 | 9.12% | 0.04% |
| Oct. 2, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | M | Warrants (right to buy) | 2666 | $0.00 | 0.0000 | 8,397,088 | 100.00% | 0.03% |
| Oct. 2, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | M | Warrants (right to buy) | 2143 | $0.44 | 0.0000 | 8,397,088 | 100.00% | 0.03% |
| Oct. 2, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | M | Warrants (right to buy) | 3500 | $0.44 | 0.0000 | 8,397,088 | 100.00% | 0.04% |
| Dec. 11, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | S | Common Stock | 6252 | $35.49 | 38,358.0000 | 8,397,088 | 14.01% | 0.07% |
| Dec. 11, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | S | Common Stock | 12381 | $36.16 | 25,977.0000 | 8,397,088 | 32.28% | 0.15% |
| Dec. 11, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | M | Common Stock | 15000 | $2.60 | 44,610.0000 | 8,397,088 | 50.66% | 0.18% |
| Nov. 30, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | S | Common Stock | 4186 | $28.65 | 21,303.0000 | 8,397,088 | 16.42% | 0.05% |
| Nov. 29, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | S | Common Stock | 2041 | $28.26 | 25,489.0000 | 8,397,088 | 7.41% | 0.02% |
| Nov. 29, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | S | Common Stock | 2162 | $27.43 | 27,530.0000 | 8,397,088 | 7.28% | 0.03% |
| Nov. 28, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | S | Common Stock | 3205 | $27.03 | 30,365.0000 | 8,397,088 | 9.55% | 0.04% |
| Nov. 28, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | S | Common Stock | 673 | $27.59 | 29,692.0000 | 8,397,088 | 2.22% | 0.01% |
| May 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | A | Common Stock | 29084 | $0.00 | 33,570.0000 | 8,397,088 | 648.33% | 0.35% |
| May 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | A | Employee stock option (right to buy) | 87251 | $0.00 | 87,251.0000 | 8,397,088 | 9999.99% | 1.04% |
| May 8, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | A | Warrants (right to buy) | 3500 | $0.44 | 3,500.0000 | 8,397,088 | 9999.99% | 0.04% |
| May 8, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | A | Warrants (right to buy) | 2143 | $0.44 | 2,143.0000 | 8,397,088 | 9999.99% | 0.03% |
| Jan. 25, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Mackaness James H | Chief Financial Officer | A | Employee stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 8,397,088 | 9999.99% | 0.36% |